Growth hormone, insulin-like growth factor-I and prolactin in small for gestational age neonates

Area of Science:

• Neonatal Endocrinology
• Pediatric Endocrinology
• Growth Hormone Physiology

Background:

• Small for gestational age (SGA) infants represent a heterogeneous group with varying growth patterns and potential endocrine dysregulation.
• Understanding the hormonal milieu in SGA neonates is crucial for assessing their growth trajectory and long-term health outcomes.

Purpose of the Study:

• To evaluate the endocrine status of small for gestational age (SGA) neonates by measuring key hormones.
• To compare the levels of growth hormone (hGH), insulin-like growth factor-I (IGF-I), and prolactin (PRL) in SGA and appropriate for gestational age (AGA) neonates during the first three days of life.

Main Methods:

• Blood samples were collected from the cord and venous blood of SGA and AGA neonates.
• Concentrations of hGH, IGF-I, and PRL were measured using established laboratory assays.
• Statistical analysis was performed to compare hormone levels between SGA and AGA groups.

Main Results:

• SGA neonates exhibited significantly higher mean concentrations of hGH, IGF-I, and PRL in cord blood compared to AGA neonates.
• Elevated hGH levels in SGA infants were associated with low IGF-I in some cases, suggesting complex regulatory mechanisms.
• On the third day of life, SGA neonates continued to show higher levels of hGH and PRL than AGA neonates, though IGF-I differences were not significant.

Conclusions:

• SGA neonates display distinct endocrine profiles characterized by elevated hGH, IGF-I, and PRL, indicating potential endocrine alterations.
• The observed hormonal heterogeneity in SGA infants suggests the presence of different underlying pathophysiological mechanisms.
• Further research is warranted to elucidate the specific endocrine pathways contributing to SGA and to guide clinical management.